Case Reports in Neurological Medicine
Volume 2015 (2015), Article ID 827168, 3 pages
http://dx.doi.org/10.1155/2015/827168

Case Report

Funicular Myelosis in a Butcher: It Was the Cream Cans

Fabian Wolpert,¹ Krisztina Baráth,² Janis Brakowski,³ Roland Renzel,¹ Michael Linnebank,¹ and Andreas R. Gantenbein1,4

¹Department of Neurology, University Hospital Zürich, Frauenklinikstrasse 26, 8091 Zürich, Switzerland
²Medizinisch Radiologisches Institut (MRI Bethanien), Toblerstrasse 51, Bahnhofplatz, Stadelhofen, 8044 Zürich, Switzerland
³Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Lenggstrasse 31, 8032 Zürich, Switzerland
⁴Neurorehabilitation, RehaClinic, Quellenstrasse 34, 5330 Bad Zurzach, Switzerland

Received 14 December 2014; Accepted 9 January 2015

Academic Editor: José Luis González-Gutiérrez

Copyright © 2015 Fabian Wolpert et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Background. Funicular myelosis is a known consequence of exposure to nitrous oxide. Nevertheless, there are only a few clinical trials assessing its long-term effects and there is no literature about the role of nutritional vitamin B12 supplementation in the context of nitrous oxide abuse. Case Descriptions. We diagnosed funicular myelosis in a young butcher, who consumed high amounts of meat regularly. Since the diagnostic process did not reveal any metabolic causes, reinterrogation of the patient uncovered recreational abuse of nitrous oxide out of whipped cream can gas cartridges. After stopping abuse and supplementation of vitamin B12, the patient recovered almost completely. Conclusions. In our case, even high nutritional vitamin B12 uptake could not compensate the noxious effects of nitrous oxide. Since there are emerging reports of increasing misuse, this should be considered in the diagnostic and therapeutic care of patients with nitrous oxide abuse. Furthermore, our case emphasizes that patients with vitamin B12 deficiency should be assessed for nitrous oxide abuse.

1. Case Presentation

The 27-year-old patient, a butcher, presented with a 4-week history of ascending symmetric numbness in the limbs, as well as tingling in the feet and fingers. He felt clumsy while writing and unsecure during walking, with report of several dropping events. The neurological examination revealed a diminished position and vibration sense and hypalgesia and hypaesthesia of the upper and lower limbs, compatible with distal symmetric polyneuropathy. However, the Romberg test was negative and the remainder of the examination was normal; in particular, there were no weaknesses or neuropsychological symptoms.

The MRI of the brain was normal. The spinal MRI showed T2-hyperintense lesions in the dorsal columns of the cervical spine (C1–C6) without contrast enhancement as typical in patients with funicular myelosis [1] (Figure 1). Elevated homocysteine plasma levels (106.0 μmol/L [5–13.5]) in addition to decreased serum vitamin B12 levels (136 ng/[180–900]) confirmed the diagnosis of funicular myelosis due to vitamin B12 deficiency (Table 1). Other blood tests were normal; in particular, there was no megaloblastic anaemia, as often seen in patients with alimentary deficiency of vitamin B12 [2]. The patient was consuming meat at least once to twice a day. Therefore, an alimentary cause of vitamin B12 deficiency was unlikely. The patient reported to be eupeptic and without gastric symptoms. Duodenogastroscopy including duodenal and gastric biopsies did not reveal signs of atrophic gastritis or other possible causes for impaired vitamin B12 resorption. Serology was negative for anti-intrinsic factor or anti-parietal cell antibodies. Reenquiry of the patient and his mother revealed a recreational abuse of nitrous oxide (N₂O) in the previous months. He acquired N₂O from gas cartridges used in whipped cream cans.

Table 1: The laboratory results showing typical changes indicating vitamin B12 deficiency.

Unit
Value
Normal range

Homocysteine
mol/L
106.0
5–13.5

Folic acid
µg/L
5.6
2.5–9.0

Vitamin B12
ng/L
136
180–900

Holotranscobalamin
pmol/L
18
>37

Anti-parietal cell antibodies
U/mL
0
<10

Anti-intrinsic factor antibodies
U/mL
0.5
<6.0

Mean corpuscular volume (MCV)
fL
88.4
80–100

Hemoglobin
g/dL
15.6
13.4–17

(a)

(b)

Figure 1: The T2-weighted axial (a) and sagittal (b) images of the cervical spine show hyperintensity (arrows) of the dorsal columns of the spinal cord. There was no contrast enhancement of the lesion (not shown).

The patient was treated with intramuscular vitamin B12 (hydroxocobalamine, 1000 μg for 6 days and thereafter 100 μg per week) and oral folic acid. He was prescribed regular physical and occupational training and was advised to stop abusing nitrous oxide. At follow-up, after 4 weeks, there was still a slightly disturbed joint-position sense in the right toe. Bimalleolar vibration sense had improved from 1/8 to 5/8 as assessed by the scale of the vibration tune (0 no sense, 8 full vibration sense). Otherwise, neurological examination was normal. He went back to work.

2. Discussion

Vitamin B12 deficiency, subsequent hyperhomocysteinaemia, and funicular myelosis have been observed in patients after exposure to nitrous oxide, and the underlying biochemical pathomechanism has been revealed. It indicates an irreversible inhibition of the active cobalt centre of vitamin B12, leading to decreased activity of 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR), a vitamin B12 dependent enzyme converting homocysteine to methionine [3].

In addition to several case reports, a small study revealed that long-term nitrous oxide exposure in operating theatres may lead to decreased vitamin B12 serum levels [4]. Interestingly, similar to the findings in our case, no significant haematological changes such as megaloblastic anaemia were observed in those patients.

Besides this abuse of nitrous oxide and the resulting degenerative effects (myelopathy and peripheral neuropathy), Cousaert et al. [5] stated an increasing misuse of nitrous oxide. The overall abuse prevalence in adolescents and young adults was reported to vary between 12% and 20% in different studies [5]. In their overview, they focused on occurring psychiatric symptoms and described cases of mild mood disorders, psychotic behaviour, fatigue, generalized weakness, and loss of memory. These symptoms often preceded the neurological impairments and were most probably caused by vitamin B12 deficiency as they decreased after high dose treatment with vitamin B12. Nevertheless, little is known about the exact neurobiological development mechanisms, the severity of the symptoms over time, or the degree of abuse. Therefore, venturous therapy suggestions like using nitrous oxide as a treatment for depression instead of electroconvulsive therapy (ECT) because of its beneficial effect (inducement of laughter, central sympathetic stimulation, and release of endogenous opioid peptides) [6] should be viewed with caution. Furthermore, because of its euphoric, anxiolytic, and narcotic effects, nitrous oxide has a high potential of dependency. Single cases of death by addictive inhalation of this substance have been described [7], and, in a large study of narcotic drug abuse deaths by the Office of the Chief Medical Examiner of Maryland between 1991 and 2006, single use of volatile drugs like nitrous oxide caused 9,4% of 149 deaths [8]. These findings show the importance of a critical controversy about the continued misuse of nitrous oxide and its consequences.

We consider this report to be worth publishing, as we found a unique constellation, where even high nutritional vitamin B12 uptake with a diet rich in meat was not able to compensate the noxious effects of N₂O. To our knowledge, there are no controlled studies available that concern the influence of nutritional supply of vitamin B12; therefore, the present case suggests that alimentary increased vitamin B12 uptake may not prevent onset of funicular myelosis upon nitrous oxide exposure. This may be of clinical importance when assessing risks for patients with abuse of or other reasons of long-term exposure to nitrous oxide. Furthermore, the case emphasizes that patients (and their next kin) should be asked for nitrous oxide exposure or abuse in cases of vitamin B12 deficiency of unknown origin.

Consent

The authors have received permission to cite any personal communications.

Disclosure

All data were obtained in the course of the diagnostic process in the mentioned institutions. No financial disclosure was reported by any of the authors.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contribution

Fabian Wolpert and Roland Renzel were in charge for the diagnostic and therapeutic care during the hospitalization. Krisztina Baráth provided MRI diagnostics and figures. Andreas R. Gantenbein was the clinical supervisor during the hospitalization phase and is the senior author who reviewed the paper during the writing process. Michael Linnebank was providing fundamental and clinical advice during the diagnostic process and while reviewing the paper. Janis Brakowski contributed his expertise as experienced psychiatric clinician through reviewing the paper.

Acknowledgment

The authors thank Dr. Violeta Mihaylova for her help during the diagnostic process.

References

S. Ilniczky, I. Jelencsik, J. Kenéz, and I. Szirmai, “MR findings in subacute combined degeneration of the spinal cord caused by nitrous oxide anaesthesia—two cases,” European Journal of Neurology, vol. 9, no. 1, pp. 101–104, 2002.

I. Elmadfa and I. Singer, “Vitamin B-12 and homocysteine status among vegetarians: a global perspective,” American Journal of Clinical Nutrition, vol. 89, no. 5, pp. 1693S–1698S, 2009.

L. Hathout and S. El-Saden, “Nitrous oxide-induced B₁₂ deficiency myelopathy: perspectives on the clinical biochemistry of vitamin B₁₂,” Journal of the Neurological Sciences, vol. 301, no. 1-2, pp. 1–8, 2011.

W. Krajewski, M. Kucharska, B. Pilacik et al., “Impaired vitamin B12 metabolic status in healthcare workers occupationally exposed to nitrous oxide,” British Journal of Anaesthesia, vol. 99, no. 6, pp. 812–818, 2007.

C. Cousaert, G. Heylens, and K. Audenaert, “Laughing gas abuse is no joke. An overview of the implications for psychiatric practice,” Clinical Neurology and Neurosurgery, vol. 115, no. 7, pp. 859–862, 2013.

B. Milne, “Nitrous oxide (laughing gas) inhalation as an alternative to electroconvulsive therapy,” Medical Hypotheses, vol. 74, no. 5, pp. 780–781, 2010.

B. Potocka-Banas, S. Majdanik, G. Dutkiewicz, K. Borowiak, and T. Janus, “Death caused by addictive inhalation of nitrous oxide,” Human and Experimental Toxicology, vol. 30, no. 11, pp. 1875–1877, 2011.

L. Li, X. Zhang, B. Levine, G. Li, H. R. Zielke, and D. R. Fowler, “Trends and pattern of drug abuse deaths in Maryland teenagers,” Journal of Forensic Sciences, vol. 56, no. 4, pp. 1029–1033, 2011.